<?xml version="1.0" encoding="UTF-8"?>
<ref id="b67-dic-2020-4-15">
 <label>67</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hung</surname>
    <given-names>IF-N</given-names>
   </name>
   <name>
    <surname>Lung</surname>
    <given-names>K-C</given-names>
   </name>
   <name>
    <surname>Tso</surname>
    <given-names>EY-K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Triple combination of interferon beta-1b, lopinavirâ€“ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</article-title>
  <source>Lancet</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)31042-4</pub-id>
 </element-citation>
</ref>
